Our Projects

Our vision is to live in a better world where children will not die of Duchenne.
Our activity is focused on promoting research and development of new treatments – while aiming to put an end to the disease soonest. When we established A.D.I. organization in 2011, there was no Duchenne research in Israel. But If there is will there is also capacity. We initiate projects and lead the advancement of Israeli research, while promoting cooperation and information sharing to progress patient care. We share the hope that the day that our vision is fulfilled is not far off.

Gene therapy
The origin of Duchenne is known to researchers. A minor defect in the gene prevents the production of an essential protein - dystrophin. There are various mutations to the disease, i.e. the defect in each patient can be in another form or letter in the gene.Some patients have multiple ...
Inhibitory drugs
A genetic defect creates a deficiency in the production of the dystrophin protein. In the absence of protein, the muscles in the kids’ body are exposed, and they are rotting every day and with every simple motor action. With muscle erosion, a space is created where fat tissue grows. (Fibrosis)...
Clinics
It is known that maintaining a high standard of treatment, tailored to each patient according to his condition, can delay the development of the disease. From the stage of diagnosis, regardless of the patient’s age, it is crucial to begin conservative treatments such as physiotherapy...